MedTrace Logo

Airway Immune Response to Allergens (Use Lay Language Here)

NCT04619017 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2023-08-31

No results posted yet for this study

Summary

Most asthma is allergic in origin. The purpose of this study is to better understand the airway immune response to inhaled allergens in order to identify factors that promote asthma.

Conditions

  • Allergic Asthma
  • Allergy to Cats
  • Allergy to Dust Mites
  • Allergic Rhinitis
  • Allergic Conjunctivitis

Interventions

BIOLOGICAL

Segmental allergen challenge

All subjects will undergo bronchoscopy with administration of standardized allergen extract to one segment of the lung.

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER

  • JOSALYN CHO

    lead OTHER

Principal Investigators

  • Josalyn L Cho, MD · University of Iowa

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-28
Primary Completion
2023-04-08
Completion
2024-03-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04619017 on ClinicalTrials.gov